Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $59.3 million.

  • Journey Medical's Total Liabilities rose 1162.51% to $59.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.3 million, marking a year-over-year increase of 1162.51%. This contributed to the annual value of $60.2 million for FY2024, which is 650.1% up from last year.
  • Latest data reveals that Journey Medical reported Total Liabilities of $59.3 million as of Q3 2025, which was up 1162.51% from $61.9 million recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Total Liabilities registered a high of $100.8 million during Q3 2021, and its lowest value of $48.5 million during Q3 2023.
  • Its 5-year average for Total Liabilities is $67.8 million, with a median of $61.9 million in 2025.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 157688.7% in 2021, then crashed by 4077.18% in 2023.
  • Over the past 5 years, Journey Medical's Total Liabilities (Quarter) stood at $55.2 million in 2021, then skyrocketed by 59.62% to $88.2 million in 2022, then plummeted by 35.93% to $56.5 million in 2023, then increased by 6.5% to $60.2 million in 2024, then decreased by 1.46% to $59.3 million in 2025.
  • Its last three reported values are $59.3 million in Q3 2025, $61.9 million for Q2 2025, and $63.4 million during Q1 2025.